Devinder Kumar
Analyst · Stacy Rasgon of Bernstein
Yes. So if you go back and look at the OpEx and in particular, we were just talking about the Enterprise, Embedded and Semi-Custom area, if you look at the OpEx, first of all, from a Q4 to Q1 standpoint, the OpEx is down. Sales and marketing specifically is down about 9% quarter-on-quarter. R&D is up slightly. And I can tell you that the R&D, without getting to the specifics, has been targeted towards those areas where we feel afford us the best longer-term opportunities from a growth standpoint and the best opportunities from improving the financial performance standpoint. And obviously, we are, in a very targeted manner, investing in the Enterprise, Embedded and Semi-Custom area which is where we've had very good traction in 2014. Our design wins continue in 2015 with revenue, as Lisa talked about earlier, in 2016. And in pursuit of those businesses, we'll go ahead and invest in those areas. As far as to your question about modulating the expenses in the areas that are more related, I guess, to the business, CG for example, with the revenues down, I have said many times that we'll modulate our expenses in line with the revenue profile, and even with the sales and marketing decrease quarter-on-quarter, is very much in line with that profile. However, the one thing I think we have to be mindful about is about the R&D investments. We do want to fund for the future in terms of investing in the product roadmap, so that we do not, in the short term, take action that sacrifice the long-term future both of the company and the product roadmap. And that's why I think your observation is right, with the revenue down 3% on a guided basis, expenses are flat but primarily it's targeted towards the R&D areas.